AMPHENOL ($APH) posted quarterly earnings results for Q4 2025 on Wednesday, January 28th. The company reported earnings of $0.97 per share, beating estimates of $0.94 by $0.03. The company also reported revenue of $6,439,000,000, beating estimates of $6,249,533,206 by $189,466,794.
You can see Quiver Quantitative's $APH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
AMPHENOL Insider Trading Activity
AMPHENOL insiders have traded $APH stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $APH stock by insiders over the last 6 months:
- CRAIG A LAMPO (SR VP & CFO) has made 0 purchases and 4 sales selling 538,000 shares for an estimated $69,197,410.
- LUC WALTER (President, HES Division) has made 0 purchases and 2 sales selling 365,118 shares for an estimated $49,163,430.
- WILLIAM J DOHERTY (President, CS Division) has made 0 purchases and 4 sales selling 386,000 shares for an estimated $47,410,748.
- MICHAEL R. IVAS (VP & Corporate Controller) has made 0 purchases and 3 sales selling 290,000 shares for an estimated $39,263,408.
- PETER STRAUB (President, ISS Division) has made 0 purchases and 3 sales selling 220,000 shares for an estimated $28,458,782.
- DAVID M SILVERMAN (Senior VP, Human Resources) has made 0 purchases and 2 sales selling 220,000 shares for an estimated $27,982,502.
- LANCE E D'AMICO (Sr. VP, Secretary & GenCounsel) sold 120,000 shares for an estimated $16,801,548
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AMPHENOL Hedge Fund Activity
We have seen 987 institutional investors add shares of AMPHENOL stock to their portfolio, and 777 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC removed 15,302,056 shares (-10.9%) from their portfolio in Q3 2025, for an estimated $1,893,629,430
- CAPITAL INTERNATIONAL INVESTORS added 14,714,177 shares (+446.9%) to their portfolio in Q3 2025, for an estimated $1,820,879,403
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 9,519,809 shares (-43.8%) from their portfolio in Q3 2025, for an estimated $1,178,076,363
- FMR LLC removed 8,847,047 shares (-8.1%) from their portfolio in Q3 2025, for an estimated $1,094,822,066
- CAPITAL RESEARCH GLOBAL INVESTORS added 8,021,284 shares (+106.9%) to their portfolio in Q3 2025, for an estimated $992,633,895
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 6,778,210 shares (+72.3%) to their portfolio in Q3 2025, for an estimated $838,803,487
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 6,362,533 shares (+693.9%) to their portfolio in Q3 2025, for an estimated $787,363,458
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AMPHENOL Congressional Stock Trading
Members of Congress have traded $APH stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $APH stock by members of Congress over the last 6 months:
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
AMPHENOL Analyst Ratings
Wall Street analysts have issued reports on $APH in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 01/12/2026
- JP Morgan issued a "Overweight" rating on 10/23/2025
- UBS issued a "Buy" rating on 10/23/2025
- Truist Securities issued a "Buy" rating on 10/23/2025
- Goldman Sachs issued a "Buy" rating on 10/23/2025
- Baird issued a "Outperform" rating on 10/10/2025
- Evercore ISI Group issued a "Outperform" rating on 10/07/2025
To track analyst ratings and price targets for AMPHENOL, check out Quiver Quantitative's $APH forecast page.
AMPHENOL Price Targets
Multiple analysts have issued price targets for $APH recently. We have seen 10 analysts offer price targets for $APH in the last 6 months, with a median target of $155.0.
Here are some recent targets:
- Samik Chatterjee from JP Morgan set a target price of $185.0 on 01/27/2026
- Joseph Spak from UBS set a target price of $174.0 on 01/14/2026
- Guy Hardwick from Barclays set a target price of $156.0 on 01/12/2026
- Asiya Merchant from Citigroup set a target price of $175.0 on 01/12/2026
- William Stein from Truist Securities set a target price of $180.0 on 12/19/2025
- Mark Delaney from Goldman Sachs set a target price of $154.0 on 10/23/2025
- Wamsi Mohan from B of A Securities set a target price of $150.0 on 10/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
